Articles |
Presented in part at the 67th Scientific Sessions of the American Heart Association, Dallas, Tex, November 1994.
From the Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham.
Correspondence to Dr M.M. Pike, Department of Medicine, Division of Cardiovascular Disease, 703 S 19th St, ZRB 308, Birmingham, AL 35294-0007.
Abstract The postischemic generation of oxygen-derived free radicals may contribute to myocardial reperfusion injury by affecting sarcolemmal ion transport. Recent evidence indicates that exposure to reactive oxygen intermediates induces rapid increases in myocardial cytosolic free Ca2+ (Ca2+i). The mechanism is undetermined but may involve disturbances in Na+ homeostasis. We tested this hypothesis by interleaving 23Na and 31P nuclear magnetic resonance (NMR) measurements of Na+i and high-energy phosphates in glucose-perfused rat hearts exposed to hydroxyl radicals generated from H2O2 and Fe3+. In separate experiments, K+i and Ca2+i were measured with 39K and 19F NMR, respectively. The hearts rapidly exhibited contracture. Threefold Na+i increases and substantial K+i depletion were observed. Glycolytic inhibition was indicated by rapid sugar phosphate accumulation and cellular energy depletion. Notably, however, severe functional and energetic deterioration and substantial elevation of Ca2+i occurred before substantial Na+i accumulation or K+i depletion was observed. Further experiments investigated the ability of pyruvate to scavenge H2O2 and to protect the myocardium from oxidant stress. Pyruvate (1 or 2.5 mmol/L) dramatically attenuated functional and energetic alterations and alterations in Na+i and K+i, whereas acetate (2.5 mmol/L) offered no protection. Unlike pyruvate, lactate (5 mmol/L) has little or no capacity to scavenge H2O2 but has similar protective effects. In conclusion, pyruvate effectively protects against H2O2/Fe3+, largely by direct H2O2 scavenging. Protection with lactate may involve intracellular pyruvate augmentation. Without exogenous pyruvate or lactate, myocardial Na+ homeostasis can be substantially altered by oxidant stress, possibly via cellular energy depletion. Excess Na+i accumulation may, in turn, hasten metabolic and functional deterioration, but a causal link with the initial alterations in function or Ca2+i was not supported.
Key Words: free radicals intracellular Na+ nuclear magnetic resonance high-energy phosphates pyruvate
This article has been cited by other articles:
![]() |
R. P Taylor, J. T Ciccolo, and J. W Starnes Effect of exercise training on the ability of the rat heart to tolerate hydrogen peroxide Cardiovasc Res, June 1, 2003; 58(3): 575 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ochiai, J. Zhang, G. Gong, Y. Zhang, J. Liu, Y. Ye, X. Wu, H. Liu, Y. Murakami, R. J. Bache, et al. Effects of augmented delivery of pyruvate on myocardial high-energy phosphate metabolism at high workstate Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1823 - H1832. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Matteucci and O. Giampietro Oxidative Stress in Families of Type 1 Diabetic Patients: Further evidence Diabetes Care, January 1, 2001; 24(1): 167 - 168. [Full Text] |
||||
![]() |
C. Groussard, I. Morel, M. Chevanne, M. Monnier, J. Cillard, and A. Delamarche Free radical scavenging and antioxidant effects of lactate ion: an in vitro study J Appl Physiol, July 1, 2000; 89(1): 169 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Mallet Pyruvate: Metabolic Protector of Cardiac Performance Experimental Biology and Medicine, February 1, 2000; 223(2): 136 - 148. [Abstract] [Full Text] |
||||
![]() |
R. Ramasamy, H. Liu, P. J Oates, and S. Schaefer Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor Zopolrestat Cardiovasc Res, April 1, 1999; 42(1): 130 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liachenko, P. Tang, R. L. Hamilton, Y. Xu, and L. Litt A Reproducible Model of Circulatory Arrest and Remote Resuscitation in Rats for NMR Investigation • Editorial Comment Stroke, June 1, 1998; 29(6): 1229 - 1239. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |